BioRegenx Files Q1 2025 10-Q
Ticker: BRGX · Form: 10-Q · Filed: May 15, 2025 · CIK: 1593184
| Field | Detail |
|---|---|
| Company | Bioregenx, INC. (BRGX) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, company-update
TL;DR
BioRegenx Q1 2025 10-Q filed. Check financials.
AI Summary
BioRegenx, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial figures and business developments are outlined within the report.
Why It Matters
This filing provides investors with the latest financial health and operational status of BioRegenx, Inc. as of March 31, 2025.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it contains detailed financial information that could reveal significant risks or opportunities for investors.
Key Numbers
- Q1 2025 — Reporting Period (First quarter of 2025)
- 000-56345 — SEC File Number (Identifier for BioRegenx's SEC filings)
Key Players & Entities
- BIOREGENX, INC. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250515 (date) — Filing date
- FINDIT, INC. (company) — Former company name
- ARTEMIS ENERGY HOLDINGS, INC. (company) — Former company name
FAQ
What is the primary business of BioRegenx, Inc.?
The filing lists the Standard Industrial Classification as SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370].
When was the company formerly known as FindIt, Inc.?
The date of the name change from FindIt, Inc. to BioRegenx, Inc. was February 19, 2021.
What is BioRegenx's state of incorporation?
BioRegenx, Inc. is incorporated in Nevada (NV).
What is the business address of BioRegenx, Inc.?
The business address is 7407 Ziegler Road, Chattanooga, TN 37421.
What fiscal year end does BioRegenx observe?
BioRegenx, Inc. observes a fiscal year end of December 31 (1231).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding BIOREGENX, INC. (BRGX).